학술논문
Morning administration of 0.4 U/kg/day insulin glargine 300 U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100 U/mL in type 1 diabetes
Document Type
Article
Author
Source
In Diabetes and Metabolism February 2018 44(1):15-21
Subject
Language
ISSN
1262-3636